KEYNOTE-355: Randomized, double-blind, phase III study of pembrolizumab + chemotherapy versus placebo + chemotherapy for previously untreated locally recurrent inoperable or metastatic triple-negative breast cancer - Cortes, J; Cescon, D W; Rugo, H S (J Clin Oncol, 2020)
et al.